about
Phase-II trials in osteosarcoma recurrences: A systematic review of past experience.Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours.Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcoma.Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients.Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE).A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) study.[Relapse after rhabdomyosarcoma in childhood and adolescence: Impact of an early detection on survival].Conservative management of a perianal rhabdomyosarcoma in a 2-year old child by Papillon's technique.
P50
Q30235839-84886378-BCCD-4600-9D24-6E2A0B8A2F2BQ31018689-E6F4B574-9ABB-4538-A687-144EDA605F71Q33390217-86687B39-7046-410A-8470-7495C2B161DEQ33805555-69E63BDF-2779-42B8-9F56-DBB6F27C5803Q36853886-8F86206D-0CD1-4DAC-9271-73CFAFE16782Q37694632-CDA24739-910A-40C0-BF6E-017D6511E20FQ38870980-FD0F1162-28FF-4567-B611-99FB421EB881Q39488682-E093F55D-81FC-4445-84A4-23C98BDD864AQ39655936-D290D76E-30EE-4D8D-8769-2DDD2C46EFF9Q39656573-02B85304-AF8F-4544-82CD-55A337EFF6B8Q39682635-BF71B268-A4D7-4E67-A980-A51BA1C88633Q40131708-8982F2E4-1E26-43F6-BB3C-7DA9C04139F3Q40358575-1FBD52C1-D96F-47DA-A215-9F4A07BF07B2
P50
description
onderzoeker
@nl
name
Nadège Corradini
@ast
Nadège Corradini
@en
Nadège Corradini
@es
Nadège Corradini
@sl
type
label
Nadège Corradini
@ast
Nadège Corradini
@en
Nadège Corradini
@es
Nadège Corradini
@sl
prefLabel
Nadège Corradini
@ast
Nadège Corradini
@en
Nadège Corradini
@es
Nadège Corradini
@sl